ARCHIVES

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

ASCO Honors Community Practices For Trial Participation.

June 1, 2007

Kennedy To Propose NIH Construction Authority, Legislation Using IOM Study Recommendations

January 13, 1989

NCAB, President’s Cancer Panel honor the late Paul Calabresi.

June 11, 2004

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

March 28, 2014

Pittsburgh Broadens Inquiry To Include Lawrence Wickerham

July 15, 1994

Panel To Take Up Issues In Grant/Peer Review System, Consider NCAB Membership Requirements

December 11, 1981